Annals of Colorectal Research

Published by: Kowsar

Lymph Node Status in Colorectal Cancer; Is There a Case for Auditing the Pathologist and the Surgeon?

Emil Salmo 1 , * and Najib Haboubi 1
Authors Information
1 Department of Histopathology, Pennine Acute Hospitals NHS Trust, Royal Oldham Hospital, Oldham, United Kingdom
Article information
  • Annals of Colorectal Research: March 31, 2019, 7 (1); e83979
  • Published Online: January 6, 2019
  • Article Type: Review Article
  • Received: September 5, 2018
  • Accepted: December 19, 2018
  • DOI: 10.5812/acr.83979

To Cite: Salmo E, Haboubi N. Lymph Node Status in Colorectal Cancer; Is There a Case for Auditing the Pathologist and the Surgeon?, Ann Colorectal Res. 2019 ; 7(1):e83979. doi: 10.5812/acr.83979.

Copyright © 2019, Annals of Colorectal Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Factors That Govern Lymph Node Yield
3. Tumour Factors
4. Anatomical Location
5. Age
6. Surgeon and the Workload
7. Pathologist
8. Strategies to Improve Lymph Node Yield
9. How Many Lymph Nodes Needed for Accurate Staging and Are Twelve Lymph Nodes Enough?
10. Does the Lymph Node Ratio Relate to Prognosis?
11. Should Lymph Node Yield be Used as a Measure of Quality Control?
12. Conclusions
  • 1. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979-94. doi: 10.1043/0003-9985(2000)124<0979:PFICC>2.0.CO;2. [PubMed: 10888773].
  • 2. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol. 1932;35(3):323-32. doi: 10.1002/path.1700350303.
  • 3. Sobin LH. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.
  • 4. Budde CN, Tsikitis VL, Deveney KE, Diggs BS, Lu KC, Herzig DO. Increasing the number of lymph nodes examined after colectomy does not improve colon cancer staging. J Am Coll Surg. 2014;218(5):1004-11. doi: 10.1016/j.jamcollsurg.2014.01.039. [PubMed: 24661856].
  • 5. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst. 2007;99(6):433-41. doi: 10.1093/jnci/djk092. [PubMed: 17374833].
  • 6. Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, et al. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: What does it mean? Dis Colon Rectum. 2008;51(3):277-83. doi: 10.1007/s10350-007-9148-5. [PubMed: 18183463].
  • 7. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst. 2005;97(3):219-25. doi: 10.1093/jnci/dji020. [PubMed: 15687365].
  • 8. Quasar Collaborative G, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet. 2007;370(9604):2020-9. doi: 10.1016/S0140-6736(07)61866-2. [PubMed: 18083404].
  • 9. [No authors listed]. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: A randomised trial. QUASAR Collaborative Group. Lancet. 2000;355(9215):1588-96. [PubMed: 10821362].
  • 10. McDonald JR, Renehan AG, O'Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: Current considerations. World J Gastrointest Surg. 2012;4(1):9-19. doi: 10.4240/wjgs.v4.i1.9. [PubMed: 22347537]. [PubMed Central: PMC3277879].
  • 11. O'Dwyer ST, Haboubi NY, Johnson JS, Gardy R. Detection of lymph node metastases in colorectal carcinoma. Colorectal Dis. 2001;3(5):288-94. [PubMed: 12790948].
  • 12. Schofield JB, Mounter NA, Mallett R, Haboubi NY. The importance of accurate pathological assessment of lymph node involvement in colorectal cancer. Colorectal Dis. 2006;8(6):460-70. doi: 10.1111/j.1463-1318.2006.01044.x. [PubMed: 16784464].
  • 13. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum. 2002;45(5):628-34. [PubMed: 12004212].
  • 14. Shen SS, Haupt BX, Ro JY, Zhu J, Bailey HR, Schwartz MR. Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med. 2009;133(5):781-6. doi: 10.1043/1543-2165-133.5.781. [PubMed: 19415953].
  • 15. Tekkis PP, Smith JJ, Heriot AG, Darzi AW, Thompson MR, Stamatakis JD, et al. A national study on lymph node retrieval in resectional surgery for colorectal cancer. Dis Colon Rectum. 2006;49(11):1673-83. doi: 10.1007/s10350-006-0691-2. [PubMed: 17019656].
  • 16. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83(4):666-72. [PubMed: 9708929].
  • 17. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: A population-based study. Ann Surg. 2006;244(4):602-10. doi: 10.1097/01.sla.0000237655.11717.50. [PubMed: 16998369]. [PubMed Central: PMC1856560].
  • 18. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002;26(3):384-9. doi: 10.1007/s00268-001-0236-8. [PubMed: 11865379].
  • 19. Canessa CE, Badia F, Fierro S, Fiol V, Hayek G. Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum. 2001;44(9):1333-6. [PubMed: 11584211].
  • 20. Dillman RO, Aaron K, Heinemann FS, McClure SE. Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer. 2009;115(9):1840-8. doi: 10.1002/cncr.24185. [PubMed: 19208427].
  • 21. Topor B, Acland R, Kolodko V, Galandiuk S. Mesorectal lymph nodes: Their location and distribution within the mesorectum. Dis Colon Rectum. 2003;46(6):779-85. doi: 10.1097/01.DCR.0000069955.51592.56. [PubMed: 12794580].
  • 22. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960-4. doi: 10.1126/science.1129139. [PubMed: 17008531].
  • 23. Luperto M, Gasparini G, Orsenigo E, Carlucci M. Factors influencing lymph node yield in colorectal cancer. Eur J Surg Oncol. 2018;44(4):544. doi: 10.1016/j.ejso.2018.01.036.
  • 24. Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J Surg Oncol. 2006;93(6):439-45. doi: 10.1002/jso.20499. [PubMed: 16615148].
  • 25. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996;106(2):209-16. [PubMed: 8712176].
  • 26. Pheby DF, Levine DF, Pitcher RW, Shepherd NA. Lymph node harvests directly influence the staging of colorectal cancer: Evidence from a regional audit. J Clin Pathol. 2004;57(1):43-7. [PubMed: 14693834]. [PubMed Central: PMC1770175].
  • 27. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298(18):2149-54. doi: 10.1001/jama.298.18.2149. [PubMed: 18000198].
  • 28. Shaw A, Collins EE, Fakis A, Patel P, Semeraro D, Lund JN. Colorectal surgeons and biomedical scientists improve lymph node harvest in colorectal cancer. Tech Coloproctol. 2008;12(4):295-8. doi: 10.1007/s10151-008-0438-2. [PubMed: 19018472].
  • 29. Rieger NA, Barnett FS, Moore JW, Ananda SS, Croxford M, Johns J, et al. Quality of pathology reporting impacts on lymph node yield in colon cancer. J Clin Oncol. 2007;25(4):463. author reply 463-4. doi: 10.1200/JCO.2006.09.2304. [PubMed: 17264350].
  • 30. Unger LW, Muckenhuber M, Riss S, Argeny S, Stift J, Mesteri I, et al. Effect of pathologist's dedication on lymph node detection rate and postoperative survival in colorectal cancer. Colorectal Dis. 2018;20(7):O173-80. doi: 10.1111/codi.14241. [PubMed: 29706021].
  • 31. Jass JR, Miller K, Northover JM. Fat clearance method versus manual dissection of lymph nodes in specimens of rectal cancer. Int J Colorectal Dis. 1986;1(3):155-6. [PubMed: 3611943].
  • 32. Pickren JW. Current concepts in cancer. Nodal clearance and detection. JAMA. 1975;231(9):969-71. [PubMed: 1173109].
  • 33. Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76(11):1165-7. [PubMed: 2688803].
  • 34. Gilchrist RK, David VC. Lymphatic spread of carcinoma of the rectum. Ann Surg. 1938;108(4):621-42. [PubMed: 17857257]. [PubMed Central: PMC1387036].
  • 35. Haboubi NY, Clark P, Kaftan SM, Schofield PF. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med. 1992;85(7):386-8. [PubMed: 1378498]. [PubMed Central: PMC1293543].
  • 36. Wang H, Safar B, Wexner SD, Denoya P, Berho M. The clinical significance of fat clearance lymph node harvest for invasive rectal adenocarcinoma following neoadjuvant therapy. Dis Colon Rectum. 2009;52(10):1767-73. doi: 10.1007/DCR.0b013e3181b14eaf. [PubMed: 19966611].
  • 37. Hernanz F, Garcia-Somacarrera E, Fernandez F. The assessment of lymph nodes missed in mesenteric tissue after standard dissection of colorectal cancer specimens. Colorectal Dis. 2010;12(7 Online):e57-60. doi: 10.1111/j.1463-1318.2009.01987.x. [PubMed: 19575743].
  • 38. Dias AR, Pereira MA, de Mello ES, Nahas SC, Cecconello I, Ribeiro UJ. Lymph node yield after neoadjuvant chemoradiotherapy in rectal cancer specimens: A randomized trial comparing two fixatives. Dis Colon Rectum. 2018;61(8):888-96. doi: 10.1097/DCR.0000000000001097. [PubMed: 29944580].
  • 39. Okada K, Sadahiro S, Ogimi T, Miyakita H, Saito G, Tanaka A, et al. Tattooing improves the detection of small lymph nodes and increases the number of retrieved lymph nodes in patients with rectal cancer who receive preoperative chemoradiotherapy: A randomized controlled clinical trial. Am J Surg. 2018;215(4):563-9. doi: 10.1016/j.amjsurg.2017.06.030. [PubMed: 28693841].
  • 40. Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, et al. Clinicopathological staging for colorectal cancer: An international documentation system (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol. 1991;6(4):325-44. [PubMed: 1912440].
  • 41. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93(8):583-96. [PubMed: 11309435].
  • 42. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21(15):2912-9. doi: 10.1200/JCO.2003.05.062. [PubMed: 12885809].
  • 43. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19(1):157-63. doi: 10.1200/JCO.2001.19.1.157. [PubMed: 11134208].
  • 44. Vather R, Sammour T, Zargar-Shoshtari K, Metcalf P, Connolly A, Hill A. Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer. Int J Colorectal Dis. 2009;24(3):283-8. doi: 10.1007/s00384-008-0540-y. [PubMed: 18716784].
  • 45. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23(34):8706-12. doi: 10.1200/JCO.2005.02.8852. [PubMed: 16314630].
  • 46. Wang J, Kulaylat M, Rockette H, Hassett J, Rajput A, Dunn KB, et al. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg. 2009;249(4):559-63. doi: 10.1097/SLA.0b013e318197f2c8. [PubMed: 19300237].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments